LGM Pharma Solutions

Irvine, California, United States
Oral Solid Dose Oral Liquids Semi-solids & Liquids Finished Dosage Forms Controlled Substances
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: LGM Pharma Solutions

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Irvine, California, United States
Website
Modalities
Oral Solid Dose, Oral Liquids, Semi-solids & Liquids, Finished Dosage Forms, Controlled Substances
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About LGM Pharma Solutions

LGM Pharma Solutions is a contract development and manufacturing organization (CDMO). Capabilities: Oral Solid Dose, Oral Liquids, Semi-solids & Liquids, Finished Dosage Forms, Controlled Substances. 3 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://lgmpharma.com/cdmo-services/commercial-scale-up-facilities-equipment/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

LGM Pharma Solutions FDA Inspection History

2025-01
2024-03
NAI VAI OAI
Date Site Type Observations Classification
2025-01-24
LGM Pharma Solutions, LLC
Irvine, California Company-level
Bioresearch Monitoring No No Action Indicated (NAI)
2024-03-01
LGM Pharma Solutions, LLC
Irvine, California Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

LGM Pharma Solutions FDA 483 Findings 4 observations · 2024-03-01 → 2024-03-01 ?

By subsystem

  • Documentation & Records 2 (50.0%)
  • Equipment & Facilities 1 (25.0%)
  • CAPA 1 (25.0%)

By severity

  • 3 — Moderate: 1
  • 2 — Minor: 3
  • Repeat observations: 0

Most severe findings

  • Moderate (3) CAPA 2024-03-01 21 CFR 211.160(a)
    Deviations from laboratory control requirements

    "Deviations from written test procedures and laboratory mechanisms are not recorded and justified."

  • Minor (2) Documentation & Records 2024-03-01 21 CFR 211.22(d)
    Procedures not in writing, fully followed

    "The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed."

  • Minor (2) Equipment & Facilities 2024-03-01 21 CFR 211.67(b)
    Written procedures not established/followed

    "Written procedures are not established and followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product."

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About LGM Pharma Solutions

How many FDA inspections does LGM Pharma Solutions have on record?
CDMO Signal tracks 2 FDA inspections for LGM Pharma Solutions, sourced from the FDA inspection database. See the full inspection history above.
Has LGM Pharma Solutions received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for LGM Pharma Solutions.
Does LGM Pharma Solutions have a CDMO Signal Score?
Not yet. LGM Pharma Solutions is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating LGM Pharma Solutions for a manufacturing program?
Use the free AI matchmaker to compare LGM Pharma Solutions against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Sterling Pharmaceutical Services
Dupo, Illinois, United States
Oral Liquids, Semi-solids & Liquids, Oral Solid Dose, Controlled Substances
Formulated Solutions
Largo, Florida, United States
Topicals, Inhalation & Nasal, Finished Dosage Forms, Oral Liquids, Semi-solids & Liquids
Mikart
Atlanta, Georgia, United States
Oral Solid Dose, Oral Liquids, Controlled Substances, Packaging & Labeling
ANI Pharmaceuticals (contract manufacturing)
Baudette, Minnesota, United States
Oral Solid Dose, Oral Liquids, Packaging & Labeling, Controlled Substances
Sovereign Pharmaceuticals
Fort Worth, Texas, United States
Oral Solid Dose, Oral Liquids, Topicals, Controlled Substances, Packaging & Labeling

Compare LGM Pharma Solutions with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on LGM Pharma Solutions
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.